Raleigh, NC - February 04, 2026 - PRESSADVANTAGE - Porter Ophthalmology announced the release of a comprehensive new ...

The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1 ...

A new treatment vertical in eye care, pharmacologic agents for refractive correction, is in the early stage of ...

Johnson & Johnson has announced the roll-out of the Acuvue Oasys Max 1-Day Multifocal for Astigmatism in the United Kingdom ...

World’s #1 Selling Contact Lens Brand ACUVUE®*1 Brings Pioneering Innovation For Astigmatic Patients With Presbyopia, ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the ...

Eyewear expresses your personality and solves your vision challenges. If you have astigmatism, getting the right glasses can ...

The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.

January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

As Johnson & Johnson seeks city incentives to help expand its Jacksonville-based vision products subsidiary, company officials are touting the growth potential of the unit.

Refractive Lens Surgery at Kingsbridge Private Hospital Group has been life-enhancing for this Co Antrim cyclist ...

Khati, 27, is asking for financial assistance to fund life-changing eye surgery that could restore his vision and allow him ...